Fact Meets Function

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185”.

This review article discusses BPC 157, a synthetic peptide, and its proposed mechanisms of action related to angiogenesis and nitric oxide regulation, responding to previous literature on the peptide’s multifunctional properties and potential medical applications. The authors address how BPC 157 may modulate the balance between protective and damaging actions of nitric oxide while promoting blood vessel formation. The evidence level is a review of existing literature rather than new primary research (review article).

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on “Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185”. Read Post »

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

This pilot study evaluated the safety profile of intravenously administered BPC157 in human subjects. The research found that intravenous BPC157 infusion was well-tolerated with no serious adverse events reported in the study population. This evidence comes from a human clinical pilot study, representing preliminary safety data for this intervention.

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Read Post »

Beta-Hydroxybutyrate but not NMN supplementation mimics caloric restriction reducing early mortality in Daphnia.

This study compared the effects of beta-hydroxybutyrate and NMN supplementation against caloric restriction in *Daphnia* (aquatic organisms), finding that beta-hydroxybutyrate supplementation replicated caloric restriction’s effect on reducing early mortality, while NMN supplementation did not produce similar benefits (animal model). The research suggests differential efficacy between these two proposed longevity interventions in this model organism, though findings in *Daphnia* may not directly translate to human physiology (animal model evidence level).

Beta-Hydroxybutyrate but not NMN supplementation mimics caloric restriction reducing early mortality in Daphnia. Read Post »

Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT).

This review article examines BPC-157, a naturally occurring 15-amino acid peptide, and its proposed cytoprotective mechanisms in the gastrointestinal tract (evidence level: review). The authors discuss evidence suggesting BPC-157 may protect GIT tissues through multiple pathways, though the review synthesizes existing literature rather than presenting new experimental data. As a narrative review, this represents a lower evidence level compared to primary human clinical trials or controlled animal studies.

Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT). Read Post »

Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.

Researchers investigated how a lysine-proline-valine (KPV) peptide affects skin cells exposed to fine dust (PM2.5), examining its effects on cell death, inflammation, and underlying cellular pathways. The peptide reduced fine dust-induced keratinocyte apoptosis and inflammatory markers by decreasing oxidative stress and suppressing MAPK/NF-κB signaling pathways. **Evidence level: Human clinical study.**

Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Read Post »

Food additives for the central nervous system, useful or harmful? An evidence-based review.

This review article examined the effects of various food additives on central nervous system function by synthesizing existing evidence on their potential benefits and harms. The authors found that while some additives (such as methylene blue) demonstrated neuroprotective properties in research settings, many commonly used additives lack sufficient human clinical evidence, with most supporting data coming from animal models and in vitro studies rather than human trials. The evidence level is a **review of human clinical, animal model, and in vitro studies**.

Food additives for the central nervous system, useful or harmful? An evidence-based review. Read Post »

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.

This systematic review examined the emerging evidence for BPC-157, a synthetic peptide, in treating orthopaedic and sports medicine conditions. The review synthesized findings from multiple studies (evidence level: review article incorporating human clinical, animal model, and in vitro research) and found that BPC-157 demonstrated potential benefits across various musculoskeletal injuries including tendon, ligament, muscle, and bone injuries, though the authors noted the need for more rigorous clinical trials to establish efficacy and safety in human populations.

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. Read Post »

Effects of piperine on intestinal permeation, pharmacodynamics and pharmacokinetics of insulin loaded chitosan coated solid lipid nanoparticles in rats – Nature

Effects of piperine on intestinal permeation, pharmacodynamics and pharmacokinetics of insulin loaded chitosan coated solid lipid nanoparticles in rats  Nature

Effects of piperine on intestinal permeation, pharmacodynamics and pharmacokinetics of insulin loaded chitosan coated solid lipid nanoparticles in rats – Nature Read Post »

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.

This in vitro study examined how the gastric pentadecapeptide BPC 157 affects angiogenesis (blood vessel formation) and nitric oxide (NO) system function. The research found that BPC 157 demonstrated pleiotropic effects that could modulate both angiogenesis and NO-dependent vascular processes, suggesting multiple potential mechanisms of action at the cellular level. This is an in vitro study, representing basic laboratory research without human or animal testing.

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System. Read Post »

Shopping Cart
Scroll to Top